Declaration of transparency and scientific rigour
This declaration acknowledges that this paper adheres to the principles
for transparent reporting and scientific rigour of preclinical research
as stated in the BJP guidelines for Design & Analysis,
Immunoblotting and Immunochemistry, and Animal Experimentation, and as
recommended by funding agencies, publishers and other organisations
engaged with supporting research.
Keywords: Physalin B; Liver
fibrosis; GLI1; Acetylation; LAP2α; HDAC1.
Abbreviations: PB, Physalin B; GLI1, glioma-associated oncogene
homologue 1; LAP2α, lamina-associated polypeptide 2 α; HDAC1, histone
hyperacetylation by histone deacetylase 1;HSCs, hepatic stellate cells;
COL1A1, collagen type I α 1 chain; CCl4, carbon
tetrachloride; BDL, bile duct ligation; α-SMA, α-smooth muscle actin;
Col1A1, collagen type I alpha 1; α‐SMA, α‐smooth muscle actin; TGFβ1,
transforming growth factor β1; TIMP-1, TIMP metallopeptidase inhibitor
1; ALT, alanine aminotransferase; AST, asparate aminotransferase; ECM,
extracellular matrix.